UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,841 | +25.1% | 2,130 | -7.6% | 0.00% | – |
| Q2 2023 | $23,857 | -72.3% | 2,305 | -76.6% | 0.00% | – |
| Q1 2022 | $86,000 | +218.5% | 9,857 | +253.4% | 0.00% | – |
| Q4 2021 | $27,000 | -42.6% | 2,789 | 0.0% | 0.00% | – |
| Q3 2021 | $47,000 | +11.9% | 2,789 | 0.0% | 0.00% | – |
| Q2 2021 | $42,000 | -22.2% | 2,789 | 0.0% | 0.00% | – |
| Q1 2021 | $54,000 | -6.9% | 2,789 | -13.5% | 0.00% | – |
| Q4 2020 | $58,000 | -6.5% | 3,224 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | -41.0% | 3,224 | -19.9% | 0.00% | – |
| Q2 2020 | $105,000 | +43.8% | 4,027 | -1.3% | 0.00% | – |
| Q1 2020 | $73,000 | -56.0% | 4,080 | -18.0% | 0.00% | – |
| Q4 2019 | $166,000 | +66.0% | 4,973 | +17.6% | 0.00% | – |
| Q3 2019 | $100,000 | -28.6% | 4,227 | 0.0% | 0.00% | – |
| Q2 2019 | $140,000 | +324.2% | 4,227 | +365.5% | 0.00% | – |
| Q1 2019 | $33,000 | +106.2% | 908 | +144.1% | 0.00% | – |
| Q4 2018 | $16,000 | -5.9% | 372 | 0.0% | 0.00% | – |
| Q3 2018 | $17,000 | -5.6% | 372 | 0.0% | 0.00% | – |
| Q2 2018 | $18,000 | – | 372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,111,050 | $9,099,000 | 4.23% |
| GREAT POINT PARTNERS LLC | 873,424 | $7,153,000 | 1.72% |
| Wildcat Capital Management, LLC | 533,139 | $4,366,000 | 1.45% |
| Opaleye Management Inc. | 238,670 | $1,955,000 | 0.88% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,949,489 | $24,156,000 | 0.44% |
| Annandale Capital, LLC | 84,331 | $691,000 | 0.27% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $206,000 | 0.18% |
| RTW INVESTMENTS, LP | 857,464 | $7,023,000 | 0.18% |
| Harel Insurance Investments & Financial Services Ltd. | 1,025,611 | $8,400,000 | 0.18% |
| BENDER ROBERT & ASSOCIATES | 41,131 | $337,000 | 0.13% |